Aytu BioScience offering 18.75M shares to raise $7.5M

Aytu BioScience offering 18.75M shares to raise $7.5M

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on commercializing novel products in the field of urology, today announced it has priced an... Read More

Tuesday May 3, 2016 0 comments Tags: Aytu BioScience, Englewood, Natesto, MiOXSYS, ProstaScint, Primsol

Aytu BioScience announces U.S. co-promotion agreement for Primsol

Aytu BioScience announces U.S. co-promotion agreement for Primsol

ENGLEWOOD -- Aytu BioScience , Inc.(OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced the company... Read More

Tuesday March 29, 2016 0 comments Tags: Englewood, Aytu BioScience, Primsol, Josh Disbrow, Allegis Pharmaceuticals